348 related articles for article (PubMed ID: 33318646)
1. Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.
Berber B; Aydin C; Kocabas F; Guney-Esken G; Yilancioglu K; Karadag-Alpaslan M; Caliseki M; Yuce M; Demir S; Tastan C
Gene Ther; 2021 Jun; 28(6):290-305. PubMed ID: 33318646
[TBL] [Abstract][Full Text] [Related]
2. CRISPR systems: Novel approaches for detection and combating COVID-19.
Safari F; Afarid M; Rastegari B; Borhani-Haghighi A; Barekati-Mowahed M; Behzad-Behbahani A
Virus Res; 2021 Mar; 294():198282. PubMed ID: 33428981
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies.
Tang WF; Tran AT; Wang LY; Horng JT
Biomed J; 2023 Apr; 46(2):100587. PubMed ID: 36849044
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.
Zhan Y; Li XP; Yin JY
Int J Biol Sci; 2021; 17(8):2080-2088. PubMed ID: 34131407
[TBL] [Abstract][Full Text] [Related]
5. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
6. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view.
Martín J; Tena N; Asuero AG
Microchem J; 2021 Aug; 167():106305. PubMed ID: 33897053
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.
Banerjee A; Mukherjee S; Maji BK
Exp Biol Med (Maywood); 2021 Jul; 246(14):1643-1649. PubMed ID: 33899542
[TBL] [Abstract][Full Text] [Related]
8. An Update on Molecular Diagnostics for COVID-19.
Islam KU; Iqbal J
Front Cell Infect Microbiol; 2020; 10():560616. PubMed ID: 33244462
[TBL] [Abstract][Full Text] [Related]
9. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
10. CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout.
Gupta R; Kazi TA; Dey D; Ghosh A; Ravichandiran V; Swarnakar S; Roy S; Biswas SR; Ghosh D
Appl Microbiol Biotechnol; 2021 Oct; 105(20):7593-7605. PubMed ID: 34542686
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 Diagnosis.
Yip CC; Sridhar S; Chan WM; Ip JD; Chu AW; Leung KH; Cheng VC; Yuen KY; To KK
Microbiol Spectr; 2022 Dec; 10(6):e0196222. PubMed ID: 36445095
[TBL] [Abstract][Full Text] [Related]
12. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas12-based detection of SARS-CoV-2.
Broughton JP; Deng X; Yu G; Fasching CL; Servellita V; Singh J; Miao X; Streithorst JA; Granados A; Sotomayor-Gonzalez A; Zorn K; Gopez A; Hsu E; Gu W; Miller S; Pan CY; Guevara H; Wadford DA; Chen JS; Chiu CY
Nat Biotechnol; 2020 Jul; 38(7):870-874. PubMed ID: 32300245
[TBL] [Abstract][Full Text] [Related]
14. CLEVER assay: A visual and rapid RNA extraction-free detection of SARS-CoV-2 based on CRISPR-Cas integrated RT-LAMP technology.
Bhatt A; Fatima Z; Ruwali M; Misra CS; Rangu SS; Rath D; Rattan A; Hameed S
J Appl Microbiol; 2022 Aug; 133(2):410-421. PubMed ID: 35396760
[TBL] [Abstract][Full Text] [Related]
15. Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
Brandsma E; Verhagen HJMP; van de Laar TJW; Claas ECJ; Cornelissen M; van den Akker E
J Infect Dis; 2021 Feb; 223(2):206-213. PubMed ID: 33535237
[TBL] [Abstract][Full Text] [Related]
16. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
Singh M; Bindal G; Misra CS; Rath D
Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
[TBL] [Abstract][Full Text] [Related]
17. FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.
Kumar M; Gulati S; Ansari AH; Phutela R; Acharya S; Azhar M; Murthy J; Kathpalia P; Kanakan A; Maurya R; Vasudevan JS; S A; Pandey R; Maiti S; Chakraborty D
Elife; 2021 Jun; 10():. PubMed ID: 34106048
[TBL] [Abstract][Full Text] [Related]
18. Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era.
Dzuvor CKO; Tettey EL; Danquah MK
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1785. PubMed ID: 35238490
[TBL] [Abstract][Full Text] [Related]
19. Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics.
Zhu N; Wong PK
SLAS Technol; 2020 Dec; 25(6):513-521. PubMed ID: 32833548
[TBL] [Abstract][Full Text] [Related]
20. Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection.
Hillary VE; Ignacimuthu S; Ceasar SA
Expert Rev Mol Diagn; 2021 Nov; 21(11):1179-1189. PubMed ID: 34409907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
